Cite
HARVARD Citation
Chen, Y. et al. (2019). Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical trial. Diabetes, obesity & metabolism. 21 (6), pp. 1464-1473. [Online].